New Novway: The company's health food business costs remain relatively stable, with no plans for price increases at this time.

People’s Finance News, April 8—Xin Nolan (300765) held an earnings briefing session on April 7. In response to a question from an investor—this year’s first-quarter rise in vitamin prices—what impact has it had on the company’s costs, and will the company’s related products be priced up accordingly? Xin Nolan replied that the costs of its health food business remain relatively stable, and there is currently no plan to raise prices.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments